Abstract
Pembrolizumab can delay progression of TNBC.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1038/s41571-020-00465-x
Journal: Nature reviews. Clinical oncology | Publication Date: Dec 21, 2020 |
Citations: 4 |
Pembrolizumab can delay progression of TNBC.
Join us for a 30 min session where you can share your feedback and ask us any queries you have